|
Recent Newsletters
Artificial sweeteners & CVD | A new malfunction risk with Abbott’s MitraClip devices | DOACs after TAVR |
News Alert: FDA warns of a new malfunction risk with Abbott’s MitraClip devices |
Heart Failure Highlights: Updated data on COVID-related myocarditis | Medtronic's new recall | NSAIDs & T2D |
SAVR after TAVR linked to a high mortality risk | Boston Scientific's new FDA approval |
Previewing TCT 2022 with Juan Granada | TEER safe for treating atrial secondary mitral regurgitation |
Economics Highlights: Cardiologists earn healthcare's highest salaries | Medtronic's big acquisition | AI's impact |
TAVR patients with CAD face a greater risk of death | Monkeypox linked to acute myocarditis |